The financials
agilon health, inc. by the numbers
agilon health, inc. (AGL) reported revenue of $1.42B in Q1 2026 (quarter ended Mar 31, 2026), down 7.3% from the same quarter a year earlier. That came with net income of $49M (3.4% of revenue). For the full year FY2025, revenue was $5.93B (−2.1% year on year) and net income −$391M. Its largest product in Jun 2026 was Medical Services at $1.49B, 100% of the disclosed total, well ahead of Other Operating at 0.1%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $1.42B | $1.53B | −7.3% |
| Operating income | $4.0M | −$22M | to a profit |
| Net income | $49M | $12M | +304% |
| Diluted EPS | $2.94 | $0.73 | +303% |
| Product | Revenue | Share |
|---|---|---|
| Medical Services | $1.49B | 100% |
| Other Operating | $1.8M | 0.1% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $1.49B (+5.2%)
Medical Services grew +7.2% year on yearOther Operating -38% year on year
Segment Latestquarter on quarteryear on year
- Medical Services$1.49B$1.49BQoQ +5.2%year on year +7.2%+5.2%+7.2%
- Other Operating$1.8M$1.8MQoQ -4.7%year on year -38%-4.7%-38%